Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

A new dataset captures more than 170 years of US state laws governing minors' legal capacity to independently consent to ...

Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness. £5 allows us to reach millions of people globally with accurate and reliable ...

The Higher Education Ministry, citing figures from the Health Ministry, said there were 214 HIV cases involving tertiary students in 2020, followed by a slight reduction of 186 cases in 2021.